National Bank of Canada’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.4K Buy
+15
New +$815 ﹤0.01% 2025
2025
Q2
Sell
-3,250
Closed -$32.8M 3024
2025
Q1
$32.8M Buy
3,250
+1,750
+117% +$176K 0.03% 392
2024
Q4
$13.4M Buy
+1,500
New +$132K 0.01% 676

Other funds holding BSX

National Bank of Canada's BSX Position: Q2 2026 in Review

National Bank of Canada reduced its Boston Scientific (BSX) stake by 24% in Q2 2026, selling an estimated $16.4M and leaving 958,975 shares worth $40.9M. The position accounts for 0.03% of the portfolio, ranked #388.

National Bank of Canada first reported a position in BSX in Q4 2021 and has held it in 19 quarters since. The position peaked at $160M in Q3 2025. 865 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • National Bank of Canada held 958,975 shares of Boston Scientific worth $40.9M as of Q2 2026.
  • National Bank of Canada sold 301,919 Boston Scientific shares in Q2 2026, an estimated $16.4M.
  • Boston Scientific made up 0.03% of National Bank of Canada's portfolio in Q2 2026, its #388 holding.
  • National Bank of Canada first reported a position in Boston Scientific in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Boston Scientific position peaked at $160M in Q3 2025.
  • 865 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.